International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Breast Cancer Clinical Trial

Official title:

Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01111201
• Other study ID #: 10-045
• Status: Completed
• Phase: N/A
• First received: April 22, 2010
• Last updated: May 30, 2012
• Start date: April 2010
• Est. completion date: March 2012

Study information

• Verified date: May 2012
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.

Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: March 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hematopoietic Stem Cell Transplant (HSCT) recipients

• Age >18 years

• Status post bone marrow transplant within last five years Breast Cancer patients:

Criteria 1 and Criteria 2 and/or 3

• Female age >18 years and current or past history of breast cancer

• Received systemic chemotherapy in the last five years

• Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3

• Age >18 years and current or past history of lymphoma

• Received systemic chemotherapy within 5 years

• Had active disease at any time within the last 5 years

Exclusion Criteria:

• Patients age< 18 years

• Breast cancer and lymphoma patients in clinical remission in the past 5 years

• Patients unable to fill the questionnaire due to language barriers

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms
• Lymphoma

Intervention

Behavioral:
• questionnaires
The intervention is a self-administered anonymous questionnaire that is voluntarily completed by the patient. Questions in Section One will cover general information about the patient including gender, age, race, country of birth, current zip code of residence, and level of education. Questions in Section Two will cover information regarding the cancer (breast/lymphoma) or transplant (allogeneic/ autologous). Questions in Section Three will cover travel history including the frequency of travel outside the United States and Canada in the last 5 years. Questions in Sections Four through Seven will obtain information about their last trip outside the United States and Canada.

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine the frequency of international travel of the targeted patients in the last 5 years.		once at the time of the clinic visit	No
Secondary	To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.		once at the time of the clinic visit	No
Secondary	To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.		once at the time of the clinic visit	No
Secondary	To obtain detailed information about their last international trip including		once at the time of the clinic visit	No
Secondary	To assess the adequacy of the questionnaire instructions		once at the time of the clinic visit	No

External Links

•   Memorial Sloan-Kettering Cancer Center